← all works
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Oncology
- Topic
- Breast Cancer Treatment Studies
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- Queen's UniversityUniversity of TorontoSunnybrook Health Science Centre
- Funders
- National Cancer InstituteGenomic HealthU.S. Department of Health and Human Services
- Keywords
- TamoxifenMedicineInternal medicineBreast cancerOncologyHazard ratioProportional hazards modelAnthracyclineChemotherapyCyclophosphamideRetrospective cohort studyGynecologyCancerConfidence interval
- Has abstract in OpenAlex
- no